Image Trademark with Serial Number 88143123
Status: 734 - Fifth Extension - Granted
Image for trademark with serial number 88143123
Serial Number
88143123
Status
734 - Fifth Extension - Granted
Status Date
2021-10-22
Filing Date
2018-10-04
Mark Drawing
2000 - Illustration: Drawing or design without any word(s)/letter(s)/ number(s) Typeset
Design Searches
260121, 260131 - Circles that are totally or partially shaded. Five or more circles.
Published for Opposition Date
2019-02-26
Attorney Name
Michelle D. Kahn
Law Office Assigned Location Code
M20
Employee Name
ORNDORFF, LINDA B
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Description of Mark
The mark consists of a stylized circle made of circles of varying size.
Goods and Services
Pharmaceutical preparations for treating cancer; pharmaceutical preparations for the treatment or prevention of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; pharmaceuticals for treating acromegaly, neuroendocrine tumors, Cushing's Disease, hyperinsulinism, and chronic pain; pharmaceutical preparations for use in immunology, oncology including immuno-oncology, cardiovascular and metabolic diseases, and infectious diseases; pharmaceuticals designed to deliver highly targeted therapeutic modulation for patients suffering from a variety of diseases, including cancer, autoimmune and inflammatory diseases including transplantation and delayed-type hypersensitivity, respiratory diseases, gastrointestinal diseases, cardiovascular and metabolic diseases, pathogen infections, musculoskeletal diseases, ophthalmologic and dermatologic diseases, genitourinary diseases, degenerative diseases, and orphan diseases; protein therapeutics namely, pharmaceutical preparations for use in immunology including rheumatology, oncology including immuno-oncology, pulmonology, gastroenterology, endocrinology, dermatology, urology, gynecology including fertility, infectiology including virology, ophthalmology, hepatology, neurology, and geriatrics; protein therapeutics, namely, proteins designed to deliver highly targeted therapeutic modulation for patients suffering from a variety of diseases, including cancer and autoimmune disorders, cytokines, interferons, tumor cell targeting and cytolytic agents, tolerogenic and antiallergic factors, growth and differentiation factors, hormones, replacement enzymes, coagulation factors, lipid binding proteins, protein factors for manufacturing of adoptive cell therapy products, anti-infectives, pain killers, and tissue repair factors; non-natural protein modifications for use in connection with a variety of therapeutic areas, namely, protein arrays for medical diagnosis purposes; pharmaceutical preparations, namely, synthetic proteins for use in immunology including rheumatology, oncology including immuno-oncology, pulmonology, gastroenterology, endocrinology, dermatology, urology, gynecology including fertility, infectiology including virology, ophthalmology, hepatology, neurology, and geriatrics
Goods and Services
Medical and pharmaceutical research services; pharmaceutical research and development; research and development in pharmacology for the purpose of treating cancer; medical research for use in oncology; pharmaceutical research for treating acromegaly, neuroendocrine tumors, Cushing's Disease, hyperinsulinism, and chronic pain; medical research for the treatment or prevention of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; providing medical and scientific research information in the field of pharmaceuticals; medical and scientific research, namely, conducting clinical trials for others; laboratory research services relating to pharmaceuticals; pharmaceutical research in the field of protein therapeutics; pharmaceutical research in the fields of immunology including rheumatology, oncology including immuno-oncology, pulmonology, gastroenterology, endocrinology, dermatology, urology, gynecology including fertility, infectiology including virology, ophthalmology, hepatology, neurology, geriatrics, laboratory medicine, clinical diagnostics, genetics and phenomics, pathology and forensics, proteomics, veterinary medicine and diagnostics, and basic research tools; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical research using a semi-synthetic organism for use in drug development; pharmaceutical research, namely, research relating to synthetic proteins incorporating one or more non-natural amino acids for improving pharmacological properties; pharmaceutical research, namely, research relating to synthetic proteins for use in connection with a wide variety of therapeutic agents
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2018-10-13
Primary Code
005
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2018-10-13
Primary Code
042
Current Trademark Owners
Party Name
Teon Therapeutics, Inc.
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Teon Therapeutics, Inc.
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Teon Therapeutics, Inc.
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Michelle D. Kahn
Address
Please log in with your Justia account to see this address.
Trademark Events
Event DateEvent Description
2018-10-08NEW APPLICATION ENTERED IN TRAM
2018-10-13NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2018-10-16NOTICE OF DESIGN SEARCH CODE E-MAILED
2019-01-16ASSIGNED TO EXAMINER
2019-01-17APPROVED FOR PUB - PRINCIPAL REGISTER
2019-02-06NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2019-02-26PUBLISHED FOR OPPOSITION
2019-02-26OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2019-04-23NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2019-09-27TEAS EXTENSION RECEIVED
2019-09-27EXTENSION 1 FILED
2019-09-27EXTENSION 1 GRANTED
2019-10-01NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2020-04-20TEAS EXTENSION RECEIVED
2020-04-20EXTENSION 2 FILED
2020-04-20EXTENSION 2 GRANTED
2020-04-22NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2020-09-24TEAS EXTENSION RECEIVED
2020-09-24EXTENSION 3 FILED
2020-09-24EXTENSION 3 GRANTED
2020-09-26NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2021-04-05TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2021-04-05ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2021-04-05TEAS CHANGE OF CORRESPONDENCE RECEIVED
2021-04-16TEAS EXTENSION RECEIVED
2021-04-16EXTENSION 4 FILED
2021-04-16EXTENSION 4 GRANTED
2021-04-20NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2021-10-14TEAS EXTENSION RECEIVED
2021-10-22CASE ASSIGNED TO INTENT TO USE PARALEGAL
2021-10-14EXTENSION 5 FILED
2021-10-22EXTENSION 5 GRANTED
2021-10-23NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED